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Objectives: This study was conducted in order to obtain information concerning the health hazards that may result from a 13 
week inhalation exposure of n-pentane in Sprague-Dawley rats. 
Methods: This study was conducted in accordance with the Organization for Economic Co-operation and Development (OECD) 
guidelines for the testing of chemicals No. 413 ‘Subchronic inhalation toxicity: 90-day study (as revised in 2009)’. The rats were 
divided into 4 groups (10 male and 10 female rats in each group), and were exposed to 0, 340, 1,530, and 6,885 ppm n-pentane 
in each exposure chamber for 6 hour/day, 5 days/week, for 13 weeks. All of the rats were sacrificed at the end of the treatment 
period. During the test period, clinical signs, mortality, body weights, food consumption, ophthalmoscopy, locomotion activity, 
urinalysis, hematology, serum biochemistry, gross findings, organ weights, and histopathology were assessed. 
Results: During the period of testing, there were no treatment related effects on the clinical findings, body weight, food con-
sumption, ophthalmoscopy, urinalysis, hematology, serum biochemistry, gross findings, relative organ weight, and histopathologi-
cal findings. 
Conclusion: The no-observable-adverse-effect level (NOAEL) of n-pentane is evaluated as being more than 6,885 ppm (20.3 mg/L) 
in both male and female rats. n-pentane was not a classified specific target organ toxicity in the globally harmonized classification 
system (GHS).
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Introduction
n-Pentane (CAS No. 109-66-0) is derived from petroleum, such 
as raw materials, natural gas, and crude oil. n-Pentane is a hy-
drocarbon solvent and a flammable liquid with an estimated 
production of 100,000-500,000 tons [1]. It is used as a compo-
nent of  aerosol propellant, as a raw material for the produc-
tion of chlorinated pentanes and pentanols, additive in liquid 
fumigants, additive in automotive fuels, and as a blowing agent 
for plastics. Further, it is employed in the production of olefin, 
hydrogen and ammonia, artificial ice manufacturing, low tem-
perature thermometers, and cosmetics in diverse applications [2].
In Korea, four workplaces with 128 workers produce ap-
proximately 584,000 tons of n-pentane per year. Additionally, 
more than 480 workers in 65 workplaces are involved in vari-
ous manufacturing industries that use approximately 3,710,000 
tons of n-pentane as the raw material [3]. 
As a volatile material, n-pentane can disperse in ambient 
conditions and workers can be readily exposed via inhalation at 
the workplaces. Therefore, the respiratory system serves as the 
primary target of n-pentane exposure.
In human exposure studies, pentane is a central nerve 
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system depressant, and can produce chemical pneumonitis or 
pulmonary edema [4]. In addition, it may cause narcosis, hem-
orrhage, anorexia, dizziness, depression, confusion, polyneu-
ropathies, seizure, and respiratory arrest [2]. Chronic exposure 
has resulted in anoxia. Human volunteers, who had an intake 
of  5,000 ppm pentane vapor for 10 minutes, showed no mu-
cous membrane irritation or other symptoms. The dermal ef-
fects of pentane vapor applied to the skin of 5 volunteers were 
studied. Erythema, hyperemia, swelling, and pigmentation 
were observed after dermal exposure [5].
There were some n-pentane inhalation toxicity tests; yet, 
all of them are non-good laboratory practice tests and further, 
exposure concentrations of  n-pentane were low. The aim of 
this study was to determine the potential subchronic inhala-
tion toxicity of n-pentane via whole-body exposure in Sprague-
Dawley (SD) rats. Inhalation exposure to n-pentane is the main 
route for humans because this chemical is volatile and can 
permeate through the skin. We carried out subchronic toxicity 
tests with n-pentane using SD rats through the Organization 
for Economic Co-operation and Development (OECD) guide-
lines in order to provide the exact toxicological information as 




Eighty 6-week-old SD rats (40 males and 40 females) were ob-
tained from a specific pathogen-free colony from the Central 
Lab Animal Inc. (Seoul, Korea); the rats were used after 6 days 
of quarantine and acclimatization. The animals were housed 
in a room maintained at a temperature of 22 ± 3oC and a rela-
tive humidity of  50 ± 20% with artificial lighting from 08:00 
to 20:00 along with 12-15 air changes per hour. The animals 
were housed individually in wire-bottomed stainless steel wire 
mesh cages that were placed in exposure chambers. They were 
allowed sterilized tap water and commercial rodent chow 
(5053-PICOLAB RODENT 20; PMI Nutrition, St. Louis, 
MO, USA) ad libitum. Before rats were obtained for research, 
the rat studies were approved by an Animal Ethics Committee 
(IACUC-11-3) in order to ensure appropriate animal care. 
Test chemical and exposure
n-Pentane was purchased from Sigma-Aldrich (Lot No. 
83396PM; St. Louis, MO, USA). Whole-body exposure cham-
bers (Shibata Co., Niigata, Japan), including a gas generator 
(Shibata Co.), were used to expose rats to n-pentane. The test 
animals were exposed to 340, 1,530, or 6,885 ppm n-pentane or 
fresh air for 6 hours per day, 5 days per week, for 13 weeks. The 
inhalation exposure was carried out from 10:00 to 16:00 in a 
stainless steel chamber (1,000 L). The experimental design was 
based on the usual working schedule for workers as well as on 
the major exposure route for the test chemical. 
Experimental design
Prior to testing, rats were evaluated by clinical observations 
and body weight determinations over a course of a 6 day quar-
antine period in order to assure freedom from potential con-
founding variables. Forty males and 40 females were randomly 
assigned to four experimental groups: three treatment groups 
receiving 340, 1,530, and 6,885 ppm n-pentane, and a vehicle 
control group. Each group consisted of 20 rats (10 males and 
10 females). All of the rats were sacrificed after treatment for 
13 weeks. The experimental concentrations were selected based 
on the results of an acute inhalation toxicity study. Considering 
the classification and safety of GHS, we selected 340 ppm as 
a low dose. One thousand five hundred thirty and 6,885 ppm 
were selected as the medium and high dose, respectively, using 
a scaling factor of 4.5.
Temperature, relative humidity, pressure, and air ventila-
tion in the chambers were recorded using an environmental 
controller (Shibata Co.). The temperature and relative humidity 
were maintained at 23.6-25.4oC and 45.4-53.9%, respectively. 
The concentrations of  n-pentane in the chambers were cali-
brated with a standard gas (RIGAS, Daejeon, Korea). The 
conditions used for detecting n-pentane by gas chromatography 
(Shimadzu Co., Kyoto, Japan) were as follows: detector tem-
perature, 120oC; oven temperature, 100oC; injector temperature, 
120oC; and injection volume, 1 mL of gas sample. n-Pentane 
vapor concentrations in the chambers were measured every 
15 minutes during exposure and were controlled to be within 
± 5% of the target concentration using a computer. The mean 
concentration, which was measured every 30 minutes for 6 
hours, was taken as the value on a given day. This was then av-
eraged over the 13-week exposure period in order to obtain the 
mean and standard deviations; the daily gas concentrations in 
the three chambers were measured at 339.8 ± 4.52, 1,540.6 ± 
25.66, and 6,917 ± 91.64 ppm, respectively.
Clinical examination
All animals were observed twice daily (before and after expo-
sure) throughout the study period for any clinical signs of toxic-
ity, morbidity, and mortality. 
Body weights of  each rat were measured at the begin-
ning of exposure and once a week during the exposure period. 
Food consumption was measured at the beginning of exposure 
Kim JK et al.
Safety and Health at Work | Vol. 3, No. 3, Sep. 30, 2012
226
www.e-shaw.org
and once a week during the exposure period. The amounts of 
food were calculated before they were supplied to each cage, 
and their remnants were measured on the next day in order to 
calculate the difference, which was regarded as the daily food 
consumption (g/rat/day).
External eye examination on all males and females was 
carried out shortly before the beginning of the experiments and 
in the last week of the exposure period. The ocular fundus was 
examined during the last week of the exposure period using an 
indirect binocular ophthalmoscope (IO-H; Neitz Instruments 
Co., Tokyo, Japan). The conjunctiva, sclera, cornea, lens, and 
iris of each eye were also examined. 
During the last week of exposure, urinalysis was carried 
out with fresh urine in order to determine the blood, bilirubin, 
urobilinogen, ketone body, protein, nitrite, glucose, pH, specific 
gravity, and leukocyte contents by using a Uriscan S-300 urine 
chemistry analyzer (Yeongdong Electronic Co., Seoul, Korea).
The animals were fasted overnight prior to necropsy and 
blood collection. Blood samples were drawn from the abdomi-
nal artery by using a syringe with a 24-gauge needle under iso-
flurane anesthesia. The blood samples were collected into com-
plete blood count (CBC) bottles containing EDTA-3K (Green 
Cross Medical Industry, Yongin, Korea), and analyzed within 
20 minutes using an automatic hematology analyzer (Advia 
120E, Bayer, Boston, MA, USA). The following parameters 
were determined: total leucocyte count (WBC), differential 
leucocyte count, neutrophils (NE), lymphocytes (LY), mono-
cytes (MO), eosinophile (EO), basophils (BA), total erythro-
cyte count (RBC), hemoglobin concentration (Hb), hematocrit 
(Hct), mean cell volume (MCV), mean cell hemoglobin (MCH), 
MCH concentration (MCHC), reticulocyte (RETIC), RBC 
distribution width (RDW), platelet distribution width (PDW), 
platelet (PLT), prothrombin time (PT), and activated partial 
thromboplastin time (APTT).
Blood samples were centrifuged at 3,000 rpm for 10 
minutes within 1 hour after collection. The sera were stored at 
-80oC in a freezer prior to analysis. The following serum bio-
chemistry parameters were evaluated using an autoanalyzer 
(HITACHI 7060, Hitachi, Tokyo, Japan; EasyLyte, Werfen 
Medical, Newtonville, IL, USA): total protein (TP), albumin 
(ALB), A/G ratio (A/G), total bilirubin (T-BIL), alkaline 
phosphatase (ALP), aspartate aminotransferase (AST), ala-
nine aminotransferase (ALT), lactate dehydrogenase (LDH), 
γ-glutamyl transferase (γ-GTP), creatinine (CREA), blood urea 
nitrogen (BUN), total cholesterol (CHOL), triglycerides (TG), 
glucose (GLU), calcium (Ca), inorganic phosphorus (IP), cre-
atine kinase (CK), sodium (Na+), and potassium (K+), chloride 
(Cl-).
At the end of the experiments, all surviving animals were 
anesthetized by isoflurane. The rats were then sacrificed by 
exsanguinations from the abdominal artery. Complete gross 
postmortem examinations were performed on all terminated 
animals.
The absolute and relative (organ-to-body weight ratios) 
weights of the following organs were measured: liver, kidney, 
spleen, adrenal gland, testis, ovary, brain, lung, heart, and thy-
mus.
The following tissues were obtained from all animals: 
liver, kidney, adrenal gland, heart, lung, cerebrum, cerebellum, 
olfactory bulb, pituitary, spleen, seminal vesicle, prostate, testis, 
epididymis, ovary, uterus, vagina, tongue, trachea, esophagus, 
thymus, thyroid, stomach, duodenum, urinary bladder, small/
large intestine, eye/harderian gland, skeletal muscle, sciatic 
nerve, pancreas, intestinal lymph node, femur, larynx, and na-
sal cavity.
The tissues were routinely processed, embedded in paraf-
fin, and sectioned at 3-5 μm. The sections were stained with he-
matoxylin-eosin stain for microscopic examination. All organs 
and tissues taken from all of the animals in the vehicle control 
and the high dose groups were examined microscopically. All 
gross lesions, as defined by the study pathologist, were also in-
cluded in the examination. 
Statistical analysis 
The means and standard deviations were calculated for all ex-
periment groups. The data were subjected to a one way analysis 
of variance, followed by Dunnett’s test, in order to determine 
the significant difference from the control. Statistical analyses 
Fig. 1. Changes of concentration in inhalation chamber during the 
experiment. 
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were performed using the SigmaStat software (version 3.5; Sys-
tat Software, San Jose, CA, USA). In all cases, p-value of < 0.05 
was used to determine the significance.
Results
n-Pentane concentration in inhalation chamber 
during the experiment
The concentrations of  n-pentane were 339.8, 1,540.6, and 
6,917.1 ppm for low, middle, and high levels of  exposure, re-
spectively, which were within 10% of the target concentrations 
(Fig. 1).
Clinical signs observed 
No treatment-related toxic signs or mortality were observed in 
any of the animals treated with n-pentane during the study pe-
riod (data not shown). 
Body weight changes and food consumption 
As shown in Fig. 2, the body weight gain of male rats statisti-
cally and significantly increased in the 340 ppm group on 83-
90 days compared with that of  the control group; yet, there 
was no dose-response relationship. As presented in Fig. 3, the 
body weight gain of female rats was not significantly different 
between the groups. On the 13th and 48th days, food consump-
tion in the male exposed groups statistically and significantly 
increased than the control group; however, there was no dose-
response relationship (data not shown). 
Clinical examination
Ophthalmologic examinations did not show any treatment-
related ocular lesions in any of the animals (data not shown).
The results of urinalysis are presented in Table 1. When 
compared with the control group, an increase of urine protein 
in a n-pentane exposed male was observed; however, it was not 
statistically significant. The other urinary parameters tested in 
both sexes were not significantly different between the treat-
ment groups and controls.
Tables 2, 3 summarize the hematological findings for 
male and female rats that inhaled n-pentane for 13 weeks. In 
males, WBC significantly increased in the low dose group (4.60 
± 0.85 K/μg) and in the middle dose group (4.59 ± 0.7 K/
μg) when compared with the control group (3.39 ± 1.03 K/
μg). NE significantly decreased in the middle dose group (21.5 
± 4.4%), whereas LY increased significantly (74.1 ± 4.7%). In 
female rats, WBC significantly decreased in the middle dose 
group (2.69 ± 0.58 K/μg) compared to the control group (3.7 ± 
1.22 K/μg). The other hematological parameters tested in both 
sexes were not significantly different between the treatment 
groups and the control group.
Table 4 shows the serum biochemical findings for male 
and female rats that inhaled n-pentane for 13 weeks. In male 
rats, ALP tended to decrease with concentration, but it was not 
statistically significant. In female rats, a statistically significant 
increase in CHOL was observed in the lose dose group (116 
± 20 mg/dL) compared to those of  the control group (92 ± 
21 mg/dL). Moreover, CHOL, in the middle dose and high 
dose group, increased more than the control group. A statisti-
cally significant decrease in the CK was observed in the middle 
dose group (418 ± 160 IU/L). The other serum biochemical 
parameters tested in both sexes were not significantly different 
between the test groups and the control group.
Fig. 2. Changes of body weight in male rats exposed to n-pentane for 
13 weeks. 
Fig. 3. Changes of body weight in female rats exposed to n-pentane for 
13 weeks.
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Table 1. Results of urinary analysis in male and female rats after inhalation of n-pentane for 13 weeks
Parameters Unit Grade
Male Female 
G1 G2 G3 G4 G1 G2 G3 G4
Blood RBC/μL - 9 9 8 9 10 9 8 10
± 1 1 1 1 0 0 2 0
+ 0 0 1 0 0 0 0 0
++ 0 0 0 0 0 1 0 0
Bilirubin mg/dL - 10 9 10 10 9 10 10 10
± 0 0 0 0 0 0 0 0
+ 0 1 0 0 1 0 0 0
Urobilinogen mg/dL
± 10 10 10 10 10 10 10 10
Keton mg/dL - 1 2 1 1 2 4 6 6
± 2 3 3 2 7 6 4 4
+ 7 5 6 7 1 0 0 0
Protein mg/dL - 2 1 1 1 5 5 6 5
± 3 0 2 0 0 5 1 2
+ 2 2 0 1 3 0 1 2
++ 3 2 6 0 2 0 1 1
+++ 0 3 0 2 0 0 1 0
++++ 0 2 1 6 0 0 0 0
Nitrite      - - 9 8 10 8 9 10 8 8
+ 1 2 0 2 1 0 2 2
Glucose mg/dL - 10 10 10 10 10 10 9 10
± 0 0 0 0 0 0 1 0
pH     - 5.0 0 0 0 0 1 0 0 0
6.0 2 2 0 0 3 2 1 3
6.5 3 7 5 3 3 2 2 3
7.0 3 1 1 1 2 4 5 1
7.5 2 0 3 2 1 1 2 2
8.0 0 0 1 1 0 1 0 0
8.5 0 0 0 1 0 0 0 1
9.0 0 0 0 2 0 0 0 0
Specific gravity mg/dL
1.005 1 0 2 0 0 2 2 2
1.010 2 2 1 4 1 4 3 3
1.015 2 1 1 2 4 3 4 1
1.020 4 4 4 2 2 1 0 2
1.025 1 3 2 2 3 0 1 2
Leukocyte WBC/μL - 0 1 0 1 5 5 8 5
± 1 0 2 1 5 3 1 5
+ 3 2 0 3 0 2 1 0
++ 6 5 7 4 0 0 0 0
+++ 0 2 1 1 0 0 0 0
G1: control group, G2: 340 ppm group, G3: 1,530 ppm group, G4: 6,885 ppm group.
The animal numbers of each group is 10.
RBC: red blood cell count, WBC, white blood cell count.
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Organ weight and histopathological analyses
At the scheduled necropsy, there were no treatment-related 
gross findings in any of the treated animals.
In male rats, the brain relative weight in the low dose 
group (0.44 ± 0.03%) significantly decreased compared to those 
of the control group (0.51 ± 0.08%). The other organs tested 
in both sexes were not significantly different between the test 
groups and the control group (Tables 5, 6).
The results of histopathological examination are present-
ed in Table 7. In high dose exposed male rats, 1 case of peri-
arteriolar inflammatory cells, 2 cases of  hepatocyte necrosis, 
1 case of inflammatory cells, 1 case of periductular inflamma-
tory cells, 1 case of periportal inflammatory cells, and 1 case 
of centrilobular inflammatory cells were observed in the livers. 
Seven cases of  tubular basophilia and 2 cases of  interstitial 
inflammatory cells were observed in the kidney. One case of 
extra medullary hematopoiesis was observed in the spleen. One 
case of concretion was observed in the prostate. Three cases of 
vacuolation, 1 case of ainar cell atrophy, 1 case of interstitial in-
flammatory cells, and 1 case of lobular atrophy were observed 
in the pancreas. One case of extra periarteriolar inflammatory 
cells was observed in the lung. In high dose exposed female 
rats, 4 cases of  microgranuloma and 1 case of  inflammatory 
cells were observed in the liver. Six cases of cortical mineraliza-
tion were observed in the kidney. One case of nasal-associated 
lymphoid tissue hyperplasia, 1 case of  olfactory epithelium 
disorganization, and 1 case of subepithelial vascular dilatation 
were observed in the nasal cavity. The other histopathological 
findings observed in both genders of the treatment groups were 
also found in the control group or were determined to be acci-
Table 2. Hematological results of male rats exposed to n-pentane for 13 weeks
Parameter Unit Control Low Middle High
WBC K/μg 3.39 ± 1.03 4.60 ± 0.85* 4.59 ± 0.70* 4.15 ± 0.80
NE % 29.5 ± 7.9 25.7 ± 5.5 21.5 ± 4.4* 28.6 ± 4.9
LY % 65.7 ± 8.5 69.7 ± 5.4 74.1 ± 4.7* 67.2 ± 4.9
MO % 2.2 ± 0.8 2.3 ± 0.4 1.8 ± 0.4 1.8 ± 0.5
EO % 2.1 ± 1.0 1.7 ± 0.4 1.9 ± 0.5 1.8 ± 0.4
BA % 0.2 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 0.2 ± 0.1
RBC M/μg 9.31 ± 0.26 9.40 ± 0.39 9.35 ± 0.39 9.28 ± 0.44
Hb g/dL 14.9 ± 0.4 14.8 ± 0.4 14.7 ± 0.7 14.7 ± 0.3
Hct % 45.9 ± 1.2 46.0 ± 1.6 45.7 ± 1.8 45.3 ± 1.4
MCV fL 49.3 ± 0.9 49.0 ± 1.1 48.9 ± 1.3 48.9 ± 0.9
MCH pg 16.0 ± 0.3 15.8 ± 0.5 15.7 ± 0.4 15.9 ± 0.5
MCHC g/dL 32.4 ± 0.3 32.2 ± 0.3 32.1 ± 0.5 32.5 ± 0.6
RDW % 12.9 ± 0.8 13.5 ± 1.0 13.7 ± 1.1 12.9 ± 1.0
PDW g/dL 2.86 ± 0.21 3.07 ± 0.24 3.06 ± 0.27 2.94 ± 0.20
RETIC % 2.00 ± 0.34 2.22 ± 0.34 2.41 ± 0.62 1.79 ± 0.46
PLT K/μL 822 ± 65 915 ± 127 884 ± 90 853 ± 109
MPV fL 8.7 ± 0.9 8.5 ± 1.0 8.8 ± 0.8 8.9 ± 1.0
PT Second 14.4 ± 1.0 13.9 ± 0.7 14.0 ± 0.6 14.4 ± 0.8
APTT Second 19.5 ± 1.1 19.7 ± 1.6 19.1 ± 1.2 19.7 ± 1.6
All values are expressed as mean ± standard deviation. 
*Significant differences as compared with the control group (p < 0.05). 
WBC: white blood cell count, NE: neutrophil, LY: lymphocyte, MO: monocyte, EO: eosinophile, BA: basophil, RBC: red blood cell count, Hb: he-
moglobin, Hct: hematocrit, MCV: mean corpuscular volume, MCH: mean corpuscular hemoglobin, MCHC: mean corpuscular hemoglobin con-
centration, RDW: RBC distribution width, PDW: platelet distribution width, RETIC: reticulocyte, PLT: platelet, PT: prothrombin time, MPV: mean 
platelet volume, PT: prothrombin time, APTT: activated partial thromboplastin time.
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dental changes without any dose-response relationship. 
Discussion
The present study was conducted in order to investigate the 
potential subchronic toxicity of  n-pentane by a 13-week re-
peated inhalation exposure to SD rats at concentrations of 0, 
340, 1,530, and 6,885 ppm, respectively. The concentration of 
the high dose group was considered as the highest level to test 
safely.
Inhalation exposure of n-pentane did not engender promi-
nent signs of toxicity based on clinical examination, urinalysis, 
blood analysis, and histopathological examination. 
Since n-pentane is a chemical that acts as a respiratory ir-
ritant, some adverse clinical signs of respiratory systems were 
expected. However, under these experimental conditions, n-
pentane at concentrations up to 6,885 ppm did not induce toxic 
symptoms in any of the animals tested. 
McKee et al. [6] reported that there were some slight but 
statistically significant increase in food consumption and body 
weight gain in the treated group; however, these changes were 
considered to be incidental. There were no changes in organ 
weight, hematology parameters, or serum chemistry values that 
were considered to be treatment related in rats exposed to 5,000, 
10,000, 20,000 mg/m3 of  pentane. In this study, the body 
weight of male rats statistically increased in the low dose group 
on the 83th-90th day compared with that of the control group; 
yet, there was no dose response relationship. This finding is 
consistent with the study of McKee et al. Insufficient data are 
available in this study in order to determine the mechanism for 
Table 3. Hematological results of female rats exposed to n-pentane for 13 weeks
Parameter Unit Control Low Middle High
WBC K/μg 3.70 ± 1.22 3.45 ± 0.85 2.69 ± 0.58* 3.36 ± 0.90
NE % 21.6 ± 4.1 26.5 ± 9.4 25.9 ± 5.9 25.9 ± 6.8
LY % 74.8 ± 3.9 70.0 ± 9.8 70.7 ± 6.3 70.5 ± 6.7
MO % 1.3 ± 0.3 1.3 ± 0.4 1.2 ± 0.4 1.4 ± 0.5
EO % 1.6 ± 0.6 1.6 ± 0.8 1.5 ± 0.3 1.7 ± 0.7
BA % 0.2 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 0.2 ± 0.1
RBC M/μg 8.58 ± 0.37 8.50 ± 0.36 8.73 ± 0.19 8.62 ± 0.30
Hb g/dL 15.3 ± 0.5 15.1 ± 0.5 15.4 ± 0.4 15.2 ± 0.4
Hct % 46.3 ± 1.6 45.3 ± 1.8 46.5 ± 0.8 45.9 ± 1.5
MCV fL 54.0 ± 1.1 53.3 ± 0.5 53.3 ± 0.7 53.3 ± 0.6
MCH pg 17.8 ± 0.6 17.8 ± 0.4 17.6 ± 0.4 17.7 ± 0.3
MCHC g/dL 33.0 ± 0.7 33.3 ± 0.7 33.1 ± 0.6 33.1 ± 0.4
RDW % 10.9 ± 0.3 11.0 ± 0.4 10.8 ± 0.3 11.0 ± 0.3
PDW g/dL 2.51 ± 0.06 2.53 ± 0.10 2.54 ± 0.08 2.56 ± 0.10
RETIC % 1.68 ± 0.27 1.44 ± 0.38 1.45 ± 0.24 1.63 ± 0.21
PLT K/μL 977 ± 80 985 ± 128 974 ± 121 989 ± 90
MPV fL 7.9 ± 0.4 8.1 ± 1.1 7.8 ± 0.6 7.8 ± 0.4
PT Second 14.5 ± 0.7 14.5 ± 0.7 14.5 ± 0.8 14.7 ± 0.7
APTT Second 17.6 ± 0.8 17.9 ± 1.1 17.1 ± 0.9 17.6 ± 1.2
All values are expressed as mean ± standard deviation. 
*Significant differences as compared with the control group (p < 0.05).
WBC: white blood cell count, NE: neutrophil, LY: lymphocyte, MO: monocyte, EO: eosinophile, BA: basophil, RBC: red blood cell count, Hb: he-
moglobin, Hct: hematocrit, MCV: mean corpuscular volume, MCH: mean corpuscular hemoglobin, MCHC: mean corpuscular hemoglobin con-
centration, RDW: RBC distribution width, PDW: platelet distribution width, RETIC: reticulocyte, PLT: platelet, PT: prothrombin time, MPV: mean 
platelet volume, PT: prothrombin time, APTT: activated partial thromboplastin time.












Table 4. Results of serum biochemical indices in male and female rats after inhalation of n-pentane for 13 weeks
Parameters Unit
Dose (ppm), male Dose (ppm), female 
Control (0) Low (340) Middle (1,530) High (6,885) Control (0) Low (340) Middle (1,530) High (6,885)
TP g/dL 6.6 ± 0.2 6.4 ± 0.2 6.5 ± 0.2 6.4 ± 0.2 6.8 ± 0.3 7.1 ± 0.3 6.8 ± 0.3 6.8 ± 0.4
ALB g/dL 2.8 ± 0.1 2.8 ± 0.1 2.8 ± 0.1 2.8 ± 0.1 3.2 ± 0.2 3.3 ± 0.2 3.1 ± 0.2 3.1 ± 0.2
A/G g/dL 0.8 ± 0 0.8 ± 0 0.8 ± 0.1 0.7 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.8 ± 0.1 0.9 ± 0.1
T-BIL mg/dL 0.04 ± 0.01 0.04 ± 0.01 0.04 ± 0.01 0.04 ± 0.01 0.05 ± 0.02 0.06 ± 0.02 0.05 ± 0.01 0.05 ± 0.01
ALP U/L 410 ± 102 402 ± 86 393 ± 70 387 ± 54 199 ± 56 251 ± 91 242 ± 71 237 ± 65
AST U/L 122 ± 48 129 ± 34 117 ± 30 109 ± 20 117 ± 29 215 ± 189 155 ± 70 118 ± 34
ALT U/L 62 ± 23 60 ± 17 62 ± 14 57 ± 13 52 ± 19 88 ± 76 75 ± 46 58 ± 18
CREA mg/dL 0.6 ± 0 0.6 ± 0 0.7 ± 0.1 0.6 ± 0 0.6 ± 0 0.7 ± 0.1 0.6 ± 0 0.6 ± 0
BUN mg/dL 16 ± 2.2 16.1 ± 1.2 16.9 ± 1.2 14.8 ± 3.4 18.5 ± 1.3 18.1 ± 2.3 17.5 ± 2.7 17.8 ± 2.8
CHOL mg/dL 66 ± 18 80 ± 15 82 ± 19 68 ± 21 92 ± 21 116 ± 20* 105 ± 14 105 ± 14
TG mg/dL 66 ± 32 91 ± 32 82 ± 23 79 ± 49 27 ± 13 32 ± 13 17 ± 7 30 ± 18
GLU mg/dL 164 ± 20 335 ± 533 168 ± 20 150 ± 10 145 ± 16 142 ± 12 143 ± 11 150 ± 17
Ca mg/dL 9.8 ± 0.3 10.1 ± 0.2 10.0 ± 0.2 9.9 ± 0.2 10.3 ± 0.4 10.5 ± 0.4 10.2 ± 0.4 10.2 ± 0.3
IP mg/dL 5.1 ± 0.4 5.5 ± 0.3 5.4 ± 0.6 5.3 ± 0.7 6.2 ± 0.6 6.0 ± 0.6 6.1 ± 0.5 6.2 ± 0.3
GGT U/L 0.5 ± 0.4 0.3 ± 0.6 0.5 ± 0.4 0.4 ± 0.3 1.0 ± 0.5 1.7 ± 1.1 1.8 ± 1.2 1.2 ± 0.4
CK IU/L 589 ± 296 681 ± 423 743 ± 438 642 ± 364 569 ± 199 621 ± 253 418 ± 160* 365 ± 201
Na mmol/L 143.5 ± 1.6 142.8 ± 1.3 143.0 ± 1.3 143.6 ± 1.6 143.2 ± 1.1 143.3 ± 1.1 144.2 ± 1.7 143.7 ± 1.2
K mmol/L 4.68 ± 0.28 4.91 ± 0.21 4.82 ± 0.25 4.65 ± 0.17 4.65 ± 0.19 4.83 ± 0.27 4.76 ± 0.25 4.64 ± 0.23
Cl mmol/L 109.9 ± 1.9 108.4 ± 1.1 108.4 ± 1.5 109.2 ± 1.6 109.7 ± 1.4 110.4 ± 1.5 111.7 ± 1.1 110.4 ± 1.6
TP: total protein, ALB: albumin, A/G: albumin/globulin ratio, T-BIL: total bilirubin, ALP: alkaline phosphatase, AST: aspartate aminotransferase, ALT: alanine aminotransferase, CREA: creati-
nine, BUN: blood urea nitrogen, CHOL: total cholesterol, TG: triglycerides, GLU: glucose, Ca: calcium, IP: inorganic phosphorus, GGT: gamma (γ)-glutamyl transferase, CK: creatine kinase, 
Na: sodium, K: potassium, Cl: chloride. 
*Significant differences as compared with the control group (p < 0.05).
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the increase in body weight.
Stadler et al. [7] observed that increases in serum calcium 
and phosphorus concentrations were seen in rats exposed to 
either 3,000 or 10,000 ppm after inhalation of pentane, 6 hour/
day, 5 days/week, for 2 weeks to either 0 (control), 1,000, 3,000, 
or 10,000 ppm. However, they could not see the unusual clini-
cal signs of toxicity, functional behavior, body weights, clinical 
pathology, and gross and microscopic pathology, including 
organ weights. In this study, increases in serum calcium and 
phosphorus concentrations were not observed.
Table 5. Relative organ weights (%) of male rats exposed to n-pentane for 13 weeks
Organ Control Low (340 ppm) Middle (1,530 ppm) High (6,885 ppm)
Liver 2.43 ± 0.27 2.48 ± 0.17 2.55 ± 0.13 2.27 ± 0.17
Kidney L 0.29 ± 0.05 0.28 ± 0.01 0.29 ± 0.02 0.29 ± 0.03
Kidney R 0.28 ± 0.06 0.28 ± 0.02 0.29 ± 0.02 0.29 ± 0.03
Spleen 0.14 ± 0.05 0.16 ± 0.02 0.17 ± 0.02 0.15 ± 0.01
Adrenal gland L 0.006 ± 0.001 0.0057 ± 0.0009 0.0060 ± 0.0009 0.0059 ± 0.0010
Adrenal gland R 0.006 ± 0.003 0.0056 ± 0.0003 0.0056 ± 0.0009 0.0057 ± 0.0009
Testis L 0.43 ± 0.09 0.35 ± 0.07 0.37 ± 0.10 0.41 ± 0.05
Testis R 0.42 ± 0.09 0.34 ± 0.07 0.36 ± 0.11 0.41 ± 0.05
Brain 0.51 ± 0.08 0.44 ± 0.03* 0.46 ± 0.03 0.49 ± 0.05
Lung 0.35 ± 0.05 0.33 ± 0.02 0.33 ± 0.03 0.35 ± 0.03
Heart 0.28 ± 0.03 0.27 ± 0.02 0.27 ± 0.03 0.27 ± 0.02
Thymus 0.07 ± 0.02 0.08 ± 0.02 0.07 ± 0.02 0.07 ± 0.02
The animal numbers of each group is 10.
*Significant differences as compared with the control group (p < 0.05).
L: left, R: right. 
Table 6. Relative organ weights (%) of female rats exposed to n-pentane for 13 weeks
Organ Control Low (340 ppm) Middle (1,530 ppm) High (6,885 ppm)
Liver 2.25 ± 0.12 2.3 ± 0.13 2.24 ± 0.13 2.28 ± 0.16
Kidney L 0.31 ± 0.02 0.3 ± 0.03 0.32 ± 0.02 0.31 ± 0.02
Kidney R 0.31 ± 0.02 0.31 ± 0.02 0.32 ± 0.02 0.31 ± 0.02
Spleen 0.18 ± 0.04 0.17 ± 0.02 0.19 ± 0.01 0.18 ± 0.02
Adrenal gland L 0.012 ± 0.002 0.011 ± 0.002 0.014 ± 0.003 0.013 ± 0.002
Adrenal gland R 0.016 ± 0.011 0.010 ± 0.002 0.012 ± 0.003 0.012 ± 0.001
Ovary L 0.014 ± 0.004 0.013 ± 0.004 0.013 ± 0.001 0.013 ± 0.004
Ovary R 0.02 ± 0.015 0.014 ± 0.002 0.015 ± 0.004 0.014 ± 0.002
Brain 0.83 ± 0.07 0.75 ± 0.08 0.82 ± 0.07 0.77 ± 0.09
Lung 0.45 ± 0.04 0.44 ± 0.04 0.44 ± 0.03 0.43 ± 0.03
Heart 0.33 ± 0.02 0.33 ± 0.02 0.33 ± 0.03 0.34 ± 0.03
The animal numbers of each group is 10.
*Significant differences as compared with the control group (p < 0.05).
L: left, R: right.
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In a 500, 2,000 mg/kg gavage administered study, the 
absolute kidney weights were significantly lower than those of 
the control, but the histopathological effects were not noted in 
the kidney, and there was no evidence of hydrocarbon induced 
nephropathy [8,9]. We could not find microscopic pathologi-
cal changes in the kidney. An increase of  urine protein in n-
pentane exposed male rats was not considered to be treatment 
related.
The increase of  WBC in male rats in the low dose and 
middle dose groups, decrease of NE, and increase of LY in the 
middle dose group were considered not to be treatment related 
in the comparison of  13-week-old SD male rats hematologi-
Table 7. Result of histopathological findings in male and female rats after inhalation of n-pentane for 13 weeks
Histopathological findings
Male Female
Control High dose Control High dose
Liver Microgranuloma 1 0 3 4
 Extra medullaryhematopoiesis 1 0 0 0
 Periarteriolar inflammatory cells 0 1 0 0
 hepatocyte necrosis 0 2 0 0
 Inflammatory cells 0 1 1 1
 Periductular inflammatory cells 0 1 0 0
 Periportal inflammatory cells 0 1 1 0
 Centrilobular inflammatory cells 0 1 1 0
Kidney Tubular basophilia 9 7 0 0
 Cortical scar 1 0 1 0
 Interstitial inflammatory cells 3 2 1 0
 Cortical mineralization 0 0 3 6
Adrenal gland Cortical vacuolation 7 6 0 0
Heart Myocardial degeneration 1 0 0 0
 Cardiomyopathy 3 0 0 0
Spleen Extra medullaryhematopoiesis 0 1 0 0
Pituitary Cyst in pars distalis present 1 0 0 0
Prostate Concretion 0 1 0 0
Thyroid  Cyst 0 0 1 0
Pancreas Vacuolation 3 3 0 0
 Acinar cell atrophy 0 1 0 0
 Interstitial inflammatory cells 0 1 0 0
 lobular atrophy 0 1 0 0
Nasal cavity NALT hyperplasia 0 0 0 1
 Olfactory epithelium disorganization 0 0 0 1
 Subepithelial vascular dilatation 0 0 0 1
Lung Periarteriolar inflammatory cells 0 1 0 0
The animal numbers of each group is 10.
NALT: nasal-associated lymphoid tissue.
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cal reference values: WBC (4.8-20.1 K/μg), NE (8.1-44.6), 
and LY (44.8-86.5). These values were in the normal range. In 
comparison with the hematological reference values of female 
rats (WBC 3.0-14.3 K/μg), the decrease of WBC in the middle 
dose group was considered to be incidental. The value of the 
CK in the middle dose female group, CHOL in the low dose fe-
male group, and the brain relative weights in the low dose male 
group were in the normal ranges: CK (305-790 IU/L), CHOL 
(51.0-155.0 mg/dL), and brain relative weight (0.3979-0.8360%) 
[10].
In this study, the neurotoxicity of n-pentane was not found 
unlike the n-hexane. n-Hexane is metabolized to a 2,5-hexane-
dione, which decreases the phosphorylation of neurofilaments, 
destroys the normal cytoskeletal matrix, and produces the giant 
axonal swelling and neurotoxicity [11]. In a study by Takeuchi 
et al. [12], n-hexane disturbed the conduction velocity of  the 
motor nerve and the mixed nerve; however, n-pentane did not. 
The solubility of n-pentane in the blood was low, and the 
blood/air partition coefficients was low as well [13]. n-Pentane 
was metabolized into a 2-pentanol by the liver [14]. Glucuroni-
dation of 2-pentanol are typically much more water-soluble [15], 
and allows for 2-pentanol elimination from the body through 
urine or feces. For this reason, the toxicity of n-pentane seems 
to be lower than other chemicals.
In conclusion, the 13-week repeated inhalation exposure 
of rats to n-pentane did not engender prominent signs of toxic-
ity based on clinical examination, urinalysis, blood analysis, 
and histopathological examination. 
The no-observable-adverse-effect level was considered to 
be more than 6,885 ppm for 6 hours per day, 5 days per week, 
for 13 weeks in rats. The present results are expected to provide 
some information on the general toxic effects and target organ 
toxicity of n-pentane via repeated inhalation exposure, which 
can aid in the process of risk assessment.
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